Quidel | QDEL - Debt


Quidel reported $2.84B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Agilent USD 3.35B 55M Sep/2025
Avanos Medical USD 133.7M 3.6M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Bruker USD 2.01B 426.8M Sep/2025
Cerus USD 84.16M 791K Dec/2024
Charles River Laboratories USD 2.63B 157.4M Sep/2025
Danaher USD 18.42B 1.56B Dec/2025
Haemonetics USD 1.22B 54K Sep/2025
Hologic USD 2.63B 104.3M Sep/2025
Illumina USD 2.58B 22M Sep/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Merit Medical Systems USD 821.15M 599K Sep/2025
Mettler Toledo International USD 2.21B 25.94M Sep/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Neogen USD 792.93M 396K Sep/2025
OraSure Technologies USD 782K 465K Jun/2024
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quidel USD 2.84B 51.1M Sep/2025
Revvity USD 3.37B 5.86M Sep/2025
STAAR Surgical USD 39.12M 1.4M Sep/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Waters USD 1.49B 52.2M Sep/2025